Logo image of CLNE

CLEAN ENERGY FUELS CORP (CLNE) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CLNE - US1844991018 - Common Stock

2.2 USD
+0.02 (+0.92%)
Last: 12/1/2025, 8:00:00 PM
2.19 USD
-0.01 (-0.45%)
Pre-Market: 12/2/2025, 7:00:29 AM
Fundamental Rating

3

Overall CLNE gets a fundamental rating of 3 out of 10. We evaluated CLNE against 209 industry peers in the Oil, Gas & Consumable Fuels industry. While CLNE seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, CLNE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CLNE had positive earnings in the past year.
In the past year CLNE had a positive cash flow from operations.
In the past 5 years CLNE always reported negative net income.
In the past 5 years CLNE always reported a positive cash flow from operatings.
CLNE Yearly Net Income VS EBIT VS OCF VS FCFCLNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

CLNE's Return On Assets of -18.59% is on the low side compared to the rest of the industry. CLNE is outperformed by 89.00% of its industry peers.
CLNE has a Return On Equity of -35.75%. This is amonst the worse of the industry: CLNE underperforms 82.78% of its industry peers.
Industry RankSector Rank
ROA -18.59%
ROE -35.75%
ROIC N/A
ROA(3y)-6.67%
ROA(5y)-6.22%
ROE(3y)-11.16%
ROE(5y)-9.58%
ROIC(3y)N/A
ROIC(5y)N/A
CLNE Yearly ROA, ROE, ROICCLNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

The Gross Margin of CLNE (27.92%) is comparable to the rest of the industry.
CLNE's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for CLNE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.4%
GM growth 5Y-4.26%
CLNE Yearly Profit, Operating, Gross MarginsCLNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

5

2. Health

2.1 Basic Checks

CLNE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CLNE has about the same amount of shares outstanding.
Compared to 5 years ago, CLNE has more shares outstanding
The debt/assets ratio for CLNE is higher compared to a year ago.
CLNE Yearly Shares OutstandingCLNE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CLNE Yearly Total Debt VS Total AssetsCLNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -0.56, we must say that CLNE is in the distress zone and has some risk of bankruptcy.
CLNE has a worse Altman-Z score (-0.56) than 73.21% of its industry peers.
CLNE has a debt to FCF ratio of 9.58. This is a negative value and a sign of low solvency as CLNE would need 9.58 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 9.58, CLNE is in line with its industry, outperforming 55.50% of the companies in the same industry.
CLNE has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
CLNE has a Debt to Equity ratio of 0.49. This is comparable to the rest of the industry: CLNE outperforms 46.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 9.58
Altman-Z -0.56
ROIC/WACCN/A
WACC9.51%
CLNE Yearly LT Debt VS Equity VS FCFCLNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 2.69 indicates that CLNE has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.69, CLNE belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
CLNE has a Quick Ratio of 2.39. This indicates that CLNE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.39, CLNE belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.69
Quick Ratio 2.39
CLNE Yearly Current Assets VS Current LiabilitesCLNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

6

3. Growth

3.1 Past

The earnings per share for CLNE have decreased by 0.00% in the last year.
The earnings per share for CLNE have been decreasing by -21.00% on average. This is quite bad
The Revenue has been growing slightly by 2.04% in the past year.
The Revenue has been growing slightly by 3.86% on average over the past years.
EPS 1Y (TTM)0%
EPS 3Y58.74%
EPS 5Y-21%
EPS Q2Q%-100%
Revenue 1Y (TTM)2.04%
Revenue growth 3Y17.62%
Revenue growth 5Y3.86%
Sales Q2Q%1.2%

3.2 Future

The Earnings Per Share is expected to grow by 59.91% on average over the next years. This is a very strong growth
Based on estimates for the next years, CLNE will show a very strong growth in Revenue. The Revenue will grow by 21.81% on average per year.
EPS Next Y-334.6%
EPS Next 2Y-91.25%
EPS Next 3Y-31.13%
EPS Next 5Y59.91%
Revenue Next Year3.78%
Revenue Next 2Y2.74%
Revenue Next 3Y5.16%
Revenue Next 5Y21.81%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLNE Yearly Revenue VS EstimatesCLNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
CLNE Yearly EPS VS EstimatesCLNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 -1

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 73.33 indicates a quite expensive valuation of CLNE.
Based on the Price/Earnings ratio, CLNE is valued a bit more expensive than 66.51% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.11. CLNE is valued rather expensively when compared to this.
CLNE is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 73.33
Fwd PE N/A
CLNE Price Earnings VS Forward Price EarningsCLNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

74.64% of the companies in the same industry are cheaper than CLNE, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CLNE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 16.08
EV/EBITDA 59.36
CLNE Per share dataCLNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

A cheap valuation may be justified as CLNE's earnings are expected to decrease with -31.13% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-91.25%
EPS Next 3Y-31.13%

0

5. Dividend

5.1 Amount

No dividends for CLNE!.
Industry RankSector Rank
Dividend Yield N/A

CLEAN ENERGY FUELS CORP

NASDAQ:CLNE (12/1/2025, 8:00:00 PM)

Premarket: 2.19 -0.01 (-0.45%)

2.2

+0.02 (+0.92%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-04 2025-11-04/amc
Earnings (Next)02-23 2026-02-23/amc
Inst Owners46.23%
Inst Owner Change-0.87%
Ins Owners1.11%
Ins Owner Change-0.59%
Market Cap482.46M
Revenue(TTM)421.84M
Net Income(TTM)-209.19M
Analysts81.33
Price Target4.58 (108.18%)
Short Float %4.94%
Short Ratio5.94
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)100%
Min EPS beat(2)100%
Max EPS beat(2)100%
EPS beat(4)4
Avg EPS beat(4)122.51%
Min EPS beat(4)100%
Max EPS beat(4)184.05%
EPS beat(8)8
Avg EPS beat(8)152.93%
EPS beat(12)11
Avg EPS beat(12)114.81%
EPS beat(16)13
Avg EPS beat(16)82.02%
Revenue beat(2)2
Avg Revenue beat(2)0.91%
Min Revenue beat(2)0.28%
Max Revenue beat(2)1.54%
Revenue beat(4)4
Avg Revenue beat(4)2.52%
Min Revenue beat(4)0.28%
Max Revenue beat(4)4.45%
Revenue beat(8)6
Avg Revenue beat(8)0.47%
Revenue beat(12)7
Avg Revenue beat(12)0.28%
Revenue beat(16)8
Avg Revenue beat(16)-0.97%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)40%
EPS NQ rev (3m)36.25%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.22%
Revenue NQ rev (1m)-1.01%
Revenue NQ rev (3m)-1.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2%
Valuation
Industry RankSector Rank
PE 73.33
Fwd PE N/A
P/S 1.14
P/FCF 16.08
P/OCF 5.12
P/B 0.82
P/tB 0.83
EV/EBITDA 59.36
EPS(TTM)0.03
EY1.36%
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)0.14
FCFY6.22%
OCF(TTM)0.43
OCFY19.54%
SpS1.92
BVpS2.67
TBVpS2.64
PEG (NY)N/A
PEG (5Y)N/A
Graham Number1.34
Profitability
Industry RankSector Rank
ROA -18.59%
ROE -35.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.92%
FCFM 7.11%
ROA(3y)-6.67%
ROA(5y)-6.22%
ROE(3y)-11.16%
ROE(5y)-9.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.4%
GM growth 5Y-4.26%
F-Score4
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 9.58
Debt/EBITDA 34.94
Cap/Depr 65.69%
Cap/Sales 15.24%
Interest Coverage N/A
Cash Conversion 1150.62%
Profit Quality N/A
Current Ratio 2.69
Quick Ratio 2.39
Altman-Z -0.56
F-Score4
WACC9.51%
ROIC/WACCN/A
Cap/Depr(3y)180.71%
Cap/Depr(5y)126.79%
Cap/Sales(3y)20.16%
Cap/Sales(5y)15.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y58.74%
EPS 5Y-21%
EPS Q2Q%-100%
EPS Next Y-334.6%
EPS Next 2Y-91.25%
EPS Next 3Y-31.13%
EPS Next 5Y59.91%
Revenue 1Y (TTM)2.04%
Revenue growth 3Y17.62%
Revenue growth 5Y3.86%
Sales Q2Q%1.2%
Revenue Next Year3.78%
Revenue Next 2Y2.74%
Revenue Next 3Y5.16%
Revenue Next 5Y21.81%
EBIT growth 1Y-198.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year257.7%
EBIT Next 3Y66.56%
EBIT Next 5Y49.8%
FCF growth 1Y143.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y163.51%
OCF growth 3Y16.07%
OCF growth 5Y39.37%

CLEAN ENERGY FUELS CORP / CLNE FAQ

What is the fundamental rating for CLNE stock?

ChartMill assigns a fundamental rating of 3 / 10 to CLNE.


Can you provide the valuation status for CLEAN ENERGY FUELS CORP?

ChartMill assigns a valuation rating of 1 / 10 to CLEAN ENERGY FUELS CORP (CLNE). This can be considered as Overvalued.


Can you provide the profitability details for CLEAN ENERGY FUELS CORP?

CLEAN ENERGY FUELS CORP (CLNE) has a profitability rating of 2 / 10.


What are the PE and PB ratios of CLEAN ENERGY FUELS CORP (CLNE) stock?

The Price/Earnings (PE) ratio for CLEAN ENERGY FUELS CORP (CLNE) is 73.33 and the Price/Book (PB) ratio is 0.82.


Can you provide the expected EPS growth for CLNE stock?

The Earnings per Share (EPS) of CLEAN ENERGY FUELS CORP (CLNE) is expected to decline by -334.6% in the next year.